Current and historical daily PE Ratio for TCBP (
TC BioPharm (Holdings) PLC
) from 2022 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. TC BioPharm (Holdings) PLC stock (TCBP) PE ratio as of Jun 09 2024 is 0.95.
More Details
TC BioPharm (Holdings) PLC (TCBP) PE Ratio (TTM) Chart
TC BioPharm (Holdings) PLC (TCBP) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 584
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| TC BioPharm (Holdings) PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 1.1 | 2024-04-05 | 1.9 |
| 2024-06-07 | 1.1 | 2024-04-04 | 2.0 |
| 2024-06-06 | 1.2 | 2024-04-03 | 1.3 |
| 2024-06-05 | 1.1 | 2024-04-02 | 1.3 |
| 2024-06-04 | 1.1 | 2024-04-01 | 1.3 |
| 2024-06-03 | 1.1 | 2024-03-28 | 1.3 |
| 2024-05-31 | 1.1 | 2024-03-27 | At Loss |
| 2024-05-30 | 1.1 | 2024-03-26 | At Loss |
| 2024-05-29 | 1.1 | 2024-03-25 | At Loss |
| 2024-05-28 | 1.1 | 2024-03-22 | At Loss |
| 2024-05-24 | 1.1 | 2024-03-21 | At Loss |
| 2024-05-23 | 1.1 | 2024-03-20 | At Loss |
| 2024-05-22 | 1.2 | 2024-03-19 | At Loss |
| 2024-05-21 | 1.2 | 2024-03-18 | At Loss |
| 2024-05-20 | 1.1 | 2024-03-15 | At Loss |
| 2024-05-17 | 1.1 | 2024-03-14 | At Loss |
| 2024-05-16 | 1.1 | 2024-03-13 | At Loss |
| 2024-05-15 | 1.1 | 2024-03-12 | At Loss |
| 2024-05-14 | 1.2 | 2024-03-11 | At Loss |
| 2024-05-13 | 1.1 | 2024-03-08 | At Loss |
| 2024-05-10 | 1.1 | 2024-03-07 | At Loss |
| 2024-05-09 | 1.2 | 2024-03-06 | At Loss |
| 2024-05-08 | 1.3 | 2024-03-05 | At Loss |
| 2024-05-07 | 1.2 | 2024-03-04 | At Loss |
| 2024-05-06 | 1.5 | 2024-03-01 | At Loss |
| 2024-05-03 | 1.5 | 2024-02-29 | At Loss |
| 2024-05-02 | 1.5 | 2024-02-28 | At Loss |
| 2024-05-01 | 1.5 | 2024-02-27 | At Loss |
| 2024-04-30 | 1.4 | 2024-02-26 | At Loss |
| 2024-04-29 | 1.5 | 2024-02-23 | At Loss |
| 2024-04-26 | 1.6 | 2024-02-22 | At Loss |
| 2024-04-25 | 1.6 | 2024-02-21 | At Loss |
| 2024-04-24 | 1.5 | 2024-02-20 | At Loss |
| 2024-04-23 | 1.6 | 2024-02-16 | At Loss |
| 2024-04-22 | 1.6 | 2024-02-15 | At Loss |
| 2024-04-19 | 1.5 | 2024-02-14 | At Loss |
| 2024-04-18 | 1.4 | 2024-02-13 | At Loss |
| 2024-04-17 | 1.4 | 2024-02-12 | At Loss |
| 2024-04-16 | 1.3 | 2024-02-09 | At Loss |
| 2024-04-15 | 1.3 | 2024-02-08 | At Loss |
| 2024-04-12 | 1.6 | 2024-02-07 | At Loss |
| 2024-04-11 | 1.8 | 2024-02-06 | At Loss |
| 2024-04-10 | 1.7 | 2024-02-05 | At Loss |
| 2024-04-09 | 1.9 | 2024-02-02 | At Loss |
| 2024-04-08 | 1.8 | 2024-02-01 | At Loss |
TC BioPharm (Holdings) PLC (TCBP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
TC BioPharm (Holdings) PLC
ISIN : US87807D4007
Share Class Description:
TCBP: ADRCompare
Compare
Traded in other countries / regions
TCBP.USAT0U.Germany IPO Date
2022-02-11Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers